Let’s get straight to it: The psychedelic stock market continues to underperform. Taking a look at our Psychedelic Invest Index, we can see that only...
Even without revenue, psychedelics companies find financing for ongoing research. The post Psychedelics Companies Report Strong Research Investment appeared...
Even without revenue, psychedelics companies find financing for ongoing research. The post Psychedlics Companies Report Strong Research Investment appeared...
Cathie Wood has built her career on holding contrarian views and her Ark Invest firm has been known to go against the grain. As such, 2022’s...
NEW YORK and BERLIN, Nov. 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company...
Congressional marijuana hearing; New poll: Americans back legalization across party lines; AOC & lawmakers press Biden on cannabis Subscribe to receive...
The self-dubbed “world’s leading psychedelic event" brought together a menagerie of industry titans, entrepreneurs, and psychedelic luminaries, showcasing...
Letzter Patient in der Phase-IIa-Studie zum Wirksamkeitsnachweis von PCN-101 (R-Ketamin) zur Behandlung von behandlungsresistenter Depression dosiert;...
The article News You Might Have Missed: Nov 14th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
October was a pretty brutal month for the psychedelic stock market no matter which way you look at it. While the rest of the stock market...